{
    "name": "molybdenum",
    "comment": "Rx",
    "other_names": [
        "Molypen"
    ],
    "classes": [
        "Trace Elements/Metals"
    ],
    "source": "https://reference.medscape.com/drug/molybdenum-344442",
    "pregnancy": {
        "common": [
            "Pregnancy Category: C",
            "Lactation: Detected in milk; use caution"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Lactation: Detected in milk; use caution"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Copper deficient patients",
                "Undiluted injection into peripheral vein (risk of infusion phlebitis)"
            ],
            "specific": []
        },
        "cautions": {
            "common": [],
            "specific": []
        }
    },
    "interactions": [
        {
            "classification_type": "Serious",
            "interaction_with": "baloxavir marboxil",
            "description": {
                "common": "molybdenum will decrease the level or effect of baloxavir marboxil by  cation binding in GI tract. Avoid or Use Alternate Drug. Baloxavir may bind to polyvalent cations resulting in decreased absorption. Studies in monkeys showed concurrent use with calcium, aluminum, or iron caused significantly decreased plasma levels. Human studies not conducted."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "omadacycline",
            "description": {
                "common": "molybdenum will decrease the level or effect of omadacycline by  inhibition of GI absorption. Applies only to oral form of both agents. Modify Therapy/Monitor Closely. Multivalent cation-containing products may impair absorption of tetracyclines, which may decrease its efficacy. Separate dosing of tetracyclines from these products."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "sarecycline",
            "description": {
                "common": "molybdenum will decrease the level or effect of sarecycline by  inhibition of GI absorption. Applies only to oral form of both agents. Modify Therapy/Monitor Closely. Multivalent cation-containing products may impair absorption of tetracyclines, which may decrease its efficacy. Separate dosing of tetracyclines from these products."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "fluoride",
            "description": {
                "common": "fluoride, molybdenum. Mechanism: pharmacodynamic synergism. Minor/Significance Unknown. Enhanced dental caries protection."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Gout",
            "percent": null
        },
        {
            "name": "like symptoms",
            "percent": null
        },
        {
            "name": "high dose",
            "percent": null
        }
    ]
}